young DI rats than in young SO rats and adult DI and SO rats. We also found that this hypotension could be prevented by the continuous infusion of AVP (2000 pg·lOO g-I min-I). The adult 01 rats were more resistant to hemorrhagic hypotension than the infant 01 rats. The reason for this is not known. In addition to AVP, angiotensin has also been thought to prevent hemorrhagic hypotension. The angiotensin levels were the same in the adult DI and SO rats both during control conditions and following bleeding. It is therefore likely that the relative resistance to hemorrhagic hypotension, observed in adult DI rats, is independent of angiotensin.
young DI rats than in young SO rats and adult DI and SO rats. We also found that this hypotension could be prevented by the continuous infusion of AVP (2000 pg·lOO g-I min-I). The adult 01 rats were more resistant to hemorrhagic hypotension than the infant 01 rats. The reason for this is not known. In addition to AVP, angiotensin has also been thought to prevent hemorrhagic hypotension. The angiotensin levels were the same in the adult DI and SO rats both during control conditions and following bleeding. It is therefore likely that the relative resistance to hemorrhagic hypotension, observed in adult DI rats, is independent of angiotensin.
The serum AVP levels were measured in the SO rats. The capacity to release AVP was at least as good in young as in adult rats. Previous studies on fetal lambs have shown that the capacity to release AVP in response to blood volume contraction is well developed even in fetal life (12) . The AVP levels recorded under basal conditions were high in both the adult and the infant 01 rats; they were 21 and 45 pg-ml", respectively. In adult rats that have been dehydrated for 48 h, the AVP concentration has been reported to be around 30 pg.ml-I (5). The SO rats in this study had been dehydrated for 10 h and subjected to anesthesia and blood vessel cannulation which might have caused the blood volume contraction. Great care had, however, been taken not to use animals that had been bled prior to carrying out the procedure. Following bleeding, the AVP levels increased in both groups, but the increase was significant only in the adult rats. It is possible, however, that the AVP levels in the infant rats were already so high during basal conditions that they represented maximal levels. albumin. The labeled cells were reincubated in autologous and homologous serum. The radioactivity present in the serum lipids and in the major phospholipid fractions of the red cell membranes was measured. Conclusions of this study are: 1) not all of the cystic fibrosis patients examined individually show an abnormal in vitro turnover of the red cell fatty acids, although they all presented abnormal fatty acid patterns for the red blood cell phospholipids, the platelet phospholipids, and the plasma lipids. 2) The in vitro abnormal fatty acid turnover occurs only in the incubations where red cells of cystic fibrosis patients are involved (in homologous and autologous serum) and not where red cells of healthy subjects are incubated in serum of cystic fibrosis patients. Consequently, the abnormal turnover is intrinsic to the red cells and is not induced by extrinsic serum factors.
Abbreviations FA, fatty acid CF, cystic fibrosis RBC, red blood cell pc, phosphatidylcholine PE, phosphatidylethanolamine From a review of the literature, it is clear that the FA patterns of the lipid fractions of biological fluids and tissues from CF patients are changed in comparison with the correspond ing patterns of healthy subjects (1, 2, 4, 7-9, II , 13, 14, 17-19,21 , 22) . Two possible explanations may be given for these abnormal FA patterns: they are due to malabsorption of essential dietary fat (7, 8) or a primary defect in FA metabolism could be involved (13, 14) . The results of our previous research rather support the latter hypothesis. Indeed, it wasshown that abnormal FA patterns can occur in both CF patients with and without pancreatic insufficiency (17, 18) . Furthermore, it was found that the in vitro turnover of FA in the phospholipids of the erythrocyte membranes is significantly higher for CF patients than for healthy children (20) . This conclusion has been drawn from in vitro experiments carried out with RBC, radioactively labeled with ['4C]linoleic and pH]palmitic acid, of CF patients with pancreatic insufficiency and of healthy children with their own serum (20) . This increased in vitro turnover of the FA in the RBC of CF patients can be intrinsic to the membrane but may also be caused by extrinsic serum factors. Until now, no experiments with standardized serum have been performed in order to try to separate intrinsic from extrinsic effects.The amount of blood to be taken from one CF child (8-10 years old) would have been too high. In this study, however, older CF patients (17-19 years old) were involved so that the amount of blood taken was no longer critical. Incorporation and reincubation experiments with radioactively labeled RBC of CF patients and healthy subjects have been carried out not only with autologous serum, but also with homologous serum.
MATERIALS AND METHODS
Materials used for the analysis of the individual phospholipid fractions of the RBC (15, 16) , for the in vitro experiments (20) and for the radioactivity measurements (20) were described previously.
Subjects and bloodcollection.
After an overnight fast of 12 h, 80 ml venous blood was collected with sodium citrate from six CF patients with pancreatic insufficiency (three female and three male, 17-19 years old) and from six healthy subjects of the same age and sex. The healthy subjects had the same bloodgroup as the matched CF patients. Six experiments, each time with RBC and serum of one CF patient and one healthy volunteer, were carried out.
In vitro experiments. The methodology of the in vitro experiments has been described previously in detail (20) . In short, blood was centrifuged and the packed RBC were washed. Next, they were incubated for 2 h with a ['4C]linoleic acid-labeled albumin solution (0.5 x 10 8 dpm/ml solution) in Krebs-Henseleit buffer containing glucose, ATP, and CoASH. The RBC were sedimented by centrifugation and washed extensively, especially with defatted human albumin solution in order to remove surface fatty acids. The RBC were resuspended for 5 min in their own serum in order to restore the normal surface pool of nonradioactive FA. After removing the serum, the radioactively labeled RBC were incubated separately with autologous and homologous serum with additives as described (20) . At various time intervals, aliquots were taken and centrifuged, and the RBC were washed and stored with dithionite at -20·e. Lipid extracts were prepared the next day and stored at -20·C under N2• The determinations of the individual phospholipid fractions (16, 19) and the measurements of the radioactivity (20) were done as described.
The following incubations were carried out: 1) RBC of CF patients in their own serum (autologous); 2) RBC ofCF patients in serum of healthy subjects (homologous); 3) RBC of healthy subjects in serum ofCF patients (homologous); 4) RBC ofhealthy subjects in their own serum (autologous).
Additionaldeterminations. Serum vitamin E and A levels were determined using a high performance liquid chromatography technique (5). The globular resistance was measured using NaCl solutions with varying concentrations (25) . The plasma nonesterified FA pattern (17) and the FA composition of the plasma cholesterol esters (18) , the RBC phospholipids (19) , and the platelet phospholipids (unpublished data) have been determined by thin layer chromatography-gas chromatography techniques , previously described.
RESULTS
As for our previous results (20) , the theoretical approach , proposed by Shohet and co-workers (23, 24) was used. The assumption was made that the incorporated FA are all taken up into PC before their transfer into PE and their final release into the serum. Again, sphingomyelin was used as internal standard.
Uptake into phosphatidylcholine. The results (mean ± SO)
obtained for the uptake of ['4C]linoleic acid from a deep membrane pool of nonesterified fatty acids into PC are shown in Table I . A two-way analysis of variance (26) was applied to these results at the significance level of 0.05. Both treatments were highly significant (P < 0.001; the variables are "time" and "combinations"). The mean uptakes in PC, obtained for the four combinations, were compared at the four separate time intervals using a one-way analysis of variance. Significant analyses of variance were followed by Newman-Keuls tests which permitted distinction of homogeneous subsets. The results are indicated in Table 1 . From 9 h on, after the reincubation was started, a significant difference was found (P < 0.02). Two homogeneous subsets existed. One was composed of combinations 1 and 2 while combinations 3 and 4 belonged to the second subset. In other words, the mean in vitro uptake of p4C]linoleic acid into PC was for the combinations where RBC of CF patients were involved significantly different from the one measured for the combinations where RBC of healthy subjects were used. No significant difference was observed between the results for combinations 1 and 2, or between those for combinations 3 and 4. This means that the serum used in these experiments had no effect on the abnormal incorporation of ['4C]linoleic acid into the PC fraction of the RBC membranes of CF patients. The observation that the mean uptake for combination I is higher than the one for combination 4 is only a confirmation of our previous results (20) . In Figure I , the individual uptake of [14C] linoleic acid into PC is shown for the six experiments. It is not possible to distinguish the uptake of patient 6 from the corresonding value ofthe normal control. The experiment was redone on RBC of the same CF patient but with RBC and the serum of two more volunteers with the same bloodgroup. However, identical results were obtained .
Transfer intophosphatidylethanolamine. In Table 2 , the results obtained for the in vitro transfer of labeled linoleic acid from PC into PE is shown. A two-way analysis of variance shows highly significant effects of both variables (time and combinations) (P < 0.001). From 9 h on, two homogeneous subsets existed (combinations I and 2; combinations 3 and 4). Since these observations are similar to those made before, the same conclusions can ... Statistical significance is indicated (one-way analysis of variance at every time interval); NS, not significant.
• 10'1 1I'II RBC dp.. PC be drawn. Again, only five of the six patients studied showed individually an abnormal transfer of FA into PE. R elease into serum. The in vitro release of p4C]linoieic acid from the RBC into autologous and homologous serum went on during the whole experiment ( Fig. 2 and Table 3 ). From 9 h on, the mean release of labeled linoleic acid into serum was significantly higher for combinations I and 2 than for 3 and 4 (P < 0.02, one-way analysis of variance). It is clear that no difference can be observed between combinations I and 2, and between 3 and 4 (combinations I and 2 form a homogeneous subset, while 3 and 4 form another one). Again , the RBC of one CF patient show normal behavior: namely, a normal release of [14C]linoleic acid from the RBC into autologous and homologous serum was measured (Fig. 2) .
Additional determinations. The results for serum vitamin E
and vitamin A and for globular resistance are shown in Table 4 .
No correlation could be observed between the serum vitamin E concentration of the CF patients and the degree of abnormality of the FA turnover in the RBC. Furthermore, there was no difference between the globular resistance of the CF patients and the healthy controls. Therefore, it is not obvious that the changes in FA turnover observed for the CF patients are caused by vitamin E deficiency as described by some investigators (6, 10, 12) . The FA compositions of the RBC , platelet, and plasma lipids for healthy subjects and for CF patient 6 are shown in Table 5 . The patterns for this particular CF patient are abnormal and are in the range of the measurements done before for a group of CF patients with pancreatic insufficiency (l7-19). [3H]palmitic acid in CF patients compared with healthy subjects (20) . No extra precautions were taken to be sure that the healthy subjects studied were not possible CF heterozygotes. It has been shown before (20) that no significant difference could be observed for the FA turnover in obligate CF heterozygotes and healthy subjects.
The results of this study are generally a confirmation of our * The results are expressed as percentage of total FA;for healthy subjects, the mean ± SD is presented.
previous findings (20) . However , an important additional observation is the fact that not all of the CF patients examined individually show abnormal in vitro behavior of their RBC. Of the 10 CF patients examined so far, nine showed individually an increased FA turnover. The RBC of one CF patient (patient 6) had completely normal in vitro behavior in our experiments.
This CF patient suffered from pancreatic insufficiency but his general condition was very good in comparison with the other CF patients studied. One wonders what might be different in this patient. From the results of Table 5 , it would not seem that it is a simple matter of FA concentrations.
The increased in vitro FA turnover can be intrinsic to the membranes or may be caused by extrinsic serum factors. From the results (Figs. I and 2 ), it appears that the abnormality occurs only in those incubations where RBC of CF patients are involved (combinations I and 2) and not where RBC of healthy subjects are incubated in serum of CF patients (combination 3). Consequently, it may be concluded that the abnormal FA turnover, occurring in the RBC phospholipids of most CF patients, is intrinsic to the RBC and is not induced by extrinsic serum factors. Unfortunately, the results obtained here cannot be compared with data in the literature, because as far as we know, they are not available. The only study which has some relation with our own work is the study by Chase et at. (3) . They reported that under some conditions CF fibroblasts cultured with ['4C]linoleic acid in different media were able to incorporate more radioactivity into their phospholipids than controls. An increased FA turnover in the RBC is clearly present in nine of the 10 CF patients examined , but no in all of them . It remains necessary to study more subjects, especially in relation to the state of their disease. An important question must be answered: namely, if this abnormality is also detectable in CF patients without pancreatic insufficiency. It is worthwhile to follow up a number of CF patients in order to detect any correlation between the FA composition of the plasma and RBC lipids, the in vitroFA turnover of the RBC, and the evolution of the disease. Furthermore, it would be of great interest to study patients with essential fatty acid deficiency, thus controls with low lipid levels oflinoleic and linolenic acids. If the FA turnover of the RBC of CF patients were still higher, our results would be more suggestive of a primary defect.
Summary
By the combination of energy and macronutrient balances, continuous open circuit computerized indirect calorimetry, and anthropometry, we have compared small for gestational age (SGA) and appropriate for gestational age (AGA) very low birthweight infants with respect to metabolizable energy intake (mean ± SE: 125.9 ± 2.5 versus 130.4 ± 3.5 keal/kg-day), energy expenditure (67.4 ± 1.3 versus 62.6 ± 0.9 kcal/kg -day), storage of energy and macronutrients and growth. Fourteen studies in six SGA infants (gestational age, 33.1 ± 0.3 weeks; birthweight, 1120 ± 30 g) and 22 studies in 13 AGA infants (gestational age, 29.3 ± 0.4 weeks; birthweight, 1155 ± 40 g) were performed.
The SGA infants had a lower absorption of fat (68.7 ± 3.2 versus 79.7 ± 1.7%) and protein (69.1 ± 3.2 versus 83.4 ± 1.5%) and hence increased (P < 0.001) energy loss in excreta (29.9 ± 2.8 versus 18.2 ± 1.5 kcal/kg-day). The significant hypermetabolism of SGA infants by 4.8 kcal/kg-day was associated with an increased fat oxidation. Despite lower energy storage, SGA infants were gaining weight (19.4 ± 0.9 g/kg-day), length (1.25 ± 0.14 em/week), and head circumference (1.16 ± 0.9 em/week) at higher rates than the AGA group. The energy storage per g weight gain was lower (P < 0.001) in the SGA group (3.0 ± 0.14 versus 4,26 ± 0.26 kcal) reflecting higher water, lower fat (22.2 ± 1.8 versus 33.8 ± 2.5%; P < 0.001) and lower protein (7.7 ± 0.5 versus 12.5 ± 0.8%; P < 0.001) contents of weight gain in the SGA group. Abbreviations SGA, small for gestational age AGA, appropriate for gestational age VLBW, very low birth weight
The infant who has suffered from intrauterine malnutrition early in the third trimester of pregnancy is potentially at risk for continued growth retardation (I, 12), as well as learning and behavioral problems (2, 13, 28) . These disorders appear to be more prominent among those children whose growth failure began before 26-34 weeksof gestation, in a pregnancy proceeding until near term (II, 16). These findings have encouraged the delivery ofSGA infants wellbefore term in an attempt to decrease perinatal mortality (41) and to avoid further undernutrition at a critical period of rapid growth rate (42). In order to devise proper feeding regimens for these high risk infants, the metabolic consequences of intrauterine growth retardation need to be understood.
The hypermetabolism of malnourished newborns has been described by a number of authors (20, 33, 35) . However, a quantitative evaluation of the energy metabolism and substrate utilization in SGA infants of VLBW kept on the same diet as AGA matched controls has not been previously documented. We have evaluated and compared the utilization and storage of energy and macro nutrients as well as the quality of growth of preterm VLBW SGA and AGA infants.
PATIENTS AND METHODS
Fourteen studies were undertaken in 6 SGA VLBW «1300 g birth weight) infants. All were below the third percentile at birth for weight, length, and head circumference as determined from Usher's intrauterine growth charts (40). Gestational age was calculated from the mothers' last menstrual period and confirmed by clinical evaluation (10) . In four, the growth retardation was due to maternal toxemia or hypertension, and no cause was determined in the remaining two infants. No malformations or intrauterine infections were documented. Three studies were conducted for three of the infants , and in two infants, two studies were performed, at intervals of 1 or 2 weeks. For comparison, 22 studies in 13 AGA VLBW infants of similar birth weight and postnatal age are presented. The clinical characteristics of these two groups of VLBW preterm infants , cared for under the same thermoneutral conditions (19) , are shown in Table 1 .
Patients selected for this series ofstudies have met the following criteria: I) birth weight is less than I.3 kg; 2) they were either appropriate for gestational age (AGA group) or small for gestational age (SGA group) as assessed from mother's last menstrual period and clinical criteria (10, 40,41); 3) they were free from congenital anomalies and intrauterine infections; 4) they were
